Cas no 298693-03-5 (Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)-)
Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- Chemical and Physical Properties
Names and Identifiers
-
- Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)-
- (4S,4'S)-2,2'-Cyclopentylidenebis[4-tert-butyl-4,5-dihydro oxazole],99%e.e.
- (4S,4'S)-2,2'-Cyclopentylidenebis[4-tert-butyl-4,5-dihydrooxazole]
- (4S,4'S)-2,2'-Cyclopentylidenebis[4-tert-butyl-4,5-dihydrooxazole], 95%, (99% ee)
- (4S,4'S)-2,2'-(Cyclopentane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole)
- AKOS037651188
- CS-16085
- 298693-03-5
- YLA69303
- (4S)-4-tert-butyl-2-[1-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]cyclopentyl]-4,5-dihydro-1,3-oxazole
- SCHEMBL25860683
- CS-0087865
- MFCD32201206
- D74658
- (4S,4''S)-2,2''-Cyclopentylidenebis[4-tert-butyl-4,5-dihydrooxazole]
-
- MDL: MFCD32201206
- Inchi: 1S/C19H32N2O2/c1-17(2,3)13-11-22-15(20-13)19(9-7-8-10-19)16-21-14(12-23-16)18(4,5)6/h13-14H,7-12H2,1-6H3/t13-,14-/m1/s1
- InChI Key: WGMVBTAYSGCATC-ZIAGYGMSSA-N
- SMILES: O1C[C@H](C(C)(C)C)N=C1C1(C2=N[C@H](CO2)C(C)(C)C)CCCC1
Computed Properties
- Exact Mass: 320.246378268g/mol
- Monoisotopic Mass: 320.246378268g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 23
- Rotatable Bond Count: 4
- Complexity: 475
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 2
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 4.5
- Topological Polar Surface Area: 43.2?2
Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-ER084-200mg |
Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- |
298693-03-5 | 97% | 200mg |
1037.0CNY | 2021-07-17 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-ER084-50mg |
Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- |
298693-03-5 | 97% | 50mg |
323.0CNY | 2021-07-17 | |
| SU ZHOU XIN JIA YUAN HUA XUE Technology Co., Ltd. | lj1417-100mg |
Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- |
298693-03-5 | 95%,99%ee | 100mg |
¥990.0 | 2024-07-19 | |
| SU ZHOU XIN JIA YUAN HUA XUE Technology Co., Ltd. | lj1417-50mg |
Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- |
298693-03-5 | 95%,99%ee | 50mg |
¥595.0 | 2024-07-19 | |
| SU ZHOU XIN JIA YUAN HUA XUE Technology Co., Ltd. | lj1416-100mg |
Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- |
298693-03-5 | 98%,99%ee | 100mg |
1404CNY | 2021-05-07 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | S81580-100mg |
(4S,?4'S)?-2,?2'-Cyclopentylidenebis[?4-?tert-butyl?-?4,?5-?dihydrooxazole] |
298693-03-5 | 97% | 100mg |
¥429.0 | 2024-07-19 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | S81580-250mg |
(4S,?4'S)?-2,?2'-Cyclopentylidenebis[?4-?tert-butyl?-?4,?5-?dihydrooxazole] |
298693-03-5 | 97% | 250mg |
¥880.0 | 2024-07-19 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | S81580-1g |
(4S,?4'S)?-2,?2'-Cyclopentylidenebis[?4-?tert-butyl?-?4,?5-?dihydrooxazole] |
298693-03-5 | 1g |
¥3456.0 | 2021-09-04 | ||
| abcr | AB541727-50 mg |
(4S,4'S)-2,2'-Cyclopentylidenebis[4-tert-butyl-4,5-dihydrooxazole], 95%, (99% ee); . |
298693-03-5 | 95% | 50mg |
€151.00 | 2023-07-10 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | S81580-100mg |
(4S,?4'S)?-2,?2'-Cyclopentylidenebis[?4-?tert-butyl?-?4,?5-?dihydrooxazole] |
298693-03-5 | 97% | 100mg |
¥429.0 | 2023-09-09 |
Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- Related Literature
-
Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
-
Fuming Xiao,Mengzhu Wang,Yunxiang Lei,Wenbo Dai,Yunbing Zhou,Miaochang Liu,Wenxia Gao,Xiaobo Huang,Huayue Wu J. Mater. Chem. C, 2020,8, 17410-17416
-
S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
-
Wenjie Zhao,Hua Hou,Yuchun Jin,Zhixiang Zeng,Xuedong Wu,Qunji Xue RSC Adv., 2014,4, 60307-60315
-
Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
Additional information on Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)-
Comprehensive Overview of Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- (CAS No. 298693-03-5)
The compound Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- (CAS No. 298693-03-5) is a specialized organic molecule with a unique structural framework. Its oxazole core, combined with cyclopentylidene and tert-butyl groups, makes it a subject of interest in pharmaceutical and material science research. This compound's stereochemistry, denoted by (4S,4'S)-, further enhances its potential for chiral applications, aligning with the growing demand for enantioselective synthesis in modern chemistry.
In recent years, the scientific community has shown increasing interest in oxazole derivatives due to their versatile biological activities and applications in drug discovery. The 2,2'-cyclopentylidenebis moiety in this compound introduces rigidity to the molecular structure, which can be leveraged for designing novel catalysts or ligands. Researchers are particularly intrigued by its potential role in asymmetric synthesis, a hot topic in organic chemistry, as it addresses the need for efficient and sustainable chiral building blocks.
The tert-butyl groups in this compound contribute to its steric hindrance, a property highly valued in the development of high-performance materials. This aligns with current trends in nanotechnology and polymer science, where bulky substituents are often used to tune material properties. Additionally, the dihydro-oxazole segment offers opportunities for further functionalization, making it a versatile intermediate in synthetic chemistry.
From an industrial perspective, CAS No. 298693-03-5 is gaining attention for its potential in green chemistry initiatives. Its structural features may enable cleaner synthetic routes, reducing waste and energy consumption—a priority for sustainable manufacturing. This resonates with global efforts to adopt eco-friendly chemical processes, a frequently searched topic among researchers and policymakers.
Analytical techniques such as NMR spectroscopy and X-ray crystallography are essential for characterizing this compound's purity and stereochemistry. These methods are widely discussed in academic circles, as accurate structural elucidation is critical for reproducibility in research. The compound's chiral centers also make it a candidate for studies in molecular recognition, a field with applications ranging from drug design to sensor development.
In summary, Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)- represents a multifaceted compound with promising applications across multiple disciplines. Its combination of steric bulk, chirality, and functional versatility positions it as a valuable asset in both academic and industrial settings, addressing contemporary challenges in chemistry and materials science.
298693-03-5 (Oxazole, 2,2'-cyclopentylidenebis[4-(1,1-dimethylethyl)-4,5-dihydro-, (4S,4'S)-) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)